Saturday, April 25, 2009: 12:30 PM-2:00 PM
Session Organizer:
Emma Webb, ACCP
Evaluation of nonprescription medication use in heart failure patients
Jill H. Cwik, Pharm.D., UMass Memorial Medical Center;
Stephanie C. Lemon, Ph.D, UMass Memorial Medical Center;
Maichi T. Tran, Pharm.D., BCPS, UMass Memorial Medical Center;
Jennifer L. Donovan, PharmD, Massachusetts College of Pharmacy and Health Sciences;
Theo E. Meyer, MD, DPhil, UMass Memorial Medical Center
Innovative clinical pharmacy services for patients undergoing percutaneous coronary interventions in a tertiary cardiology center
Julie Methot, B.Pharm., Ph.D., Quebec Heart Institute (H�pital Laval) / Faculty of pharmacy, Universit� Laval;
Isabelle Taillon, M.Sc., Quebec Heart Institute (H�pital Laval) / Faculty of pharmacy, Universit� Laval;
Marie-Jos�e Boily, M.Sc., Quebec Heart Institute (H�pital Laval);
Sylvain Gilbert, B.Sc., Quebec Heart Institute (H�pital Laval) / Faculty of pharmacy, Universit� Laval;
Karine Lejeune, M.Sc., Quebec Heart Institute (H�pital Laval);
Michelle Bernard-Genest, M.Sc., Quebec Heart Institute (H�pital Laval);
Olivier Bertrand, MD, Ph.D., Quebec Heart Institute (H�pital Laval) / Faculty of medicine, Universit� Laval
Accuracy assessment of pharmacogenetically-predicted warfarin dosing in patients of a university hospital anticoagulation clinic
Paul B. Shaw, PharmD, UMass Memorial Medical Center;
Jennifer L. Donovan, PharmD, Massachusetts College of Pharmacy and Health Sciences;
Maichi T. Tran, PharmD, UMass Memorial Medical Center;
Pam Burgwinkle, NP, UMass Memorial Medical Center;
Joel Gore, MD, UMass Memorial Medical Center
Utilization of transdermal lidocaine patches in rib fractures caused by thoracic blunt trauma injuries
Gina Alvis, Pharm.D., UMassMemorial Medical Center;
Brian S. Smith, Pharm.D., BCPS, UMassMemorial Medical Center;
Timothy Emhoff, MD FACS, UMassMemorial Medical Center;
Jeffrey J. Fong, Pharm.D., BCPS, UMassMemorial Medical Center
Implementation of a diabetic ketoacidosis order set reduces the risk of hypoglycemia
Courtney A. Sheehan, PharmD, BCPS, Clarian Health/Methodist Hospital;
Judith A Jacobi, PharmD, BCPS, FCCM, FCCP, Clarian Health/Methodist Hospital;
Kari L Roemke, PharmD, BCPS, Clarian Health/Methodist Hospital
Drug use evaluation of protamine and phytonadione: are the doses appropriate?
Teena Abraham, B.S., M.S., Pharm.D., BCPS, New York Methodist Hospital;
Nasser Saad, B.S., Pharm.D., New York Methodist Hospital;
Fabienne Vastey, B.S., Pharm.D., New York Methodist Hospital;
Eric Balmir, B.S., M.S., New York Methodist Hospital;
Amy Wang, Pharm.D., MBA, New York Methodist Hospital
Evaluation of a weight-based heparin dosing protocol in obese patients
A. Kendall Gross, PharmD, University of Kentucky HealthCare, Pharmacy Services;
Tracy E. Macaulay, Pharm.D., BCPS, University of Kentucky HealthCare, Pharmacy Services;
Douglas T. Steinke, Ph.D., University of Kentucky College of Pharmacy;
Daniel A. Lewis, PharmD, BCPS, University of Kentucky HealthCare, Pharmacy Services
Acquisition of resistance in urinary tract organisms infecting patients with spinal cord injury
Young R. Lee, Pharm.D., Texas Tech University Health Sciences Center and the Dallas Veterans Affairs Medical Center;
Sara D. Brouse, Pharm.D., BCPS, Texas Tech University Health Sciences Center and the Dallas Veterans Affairs Medical Center;
Susan Duquaine, Pharm.D., BCPS, VA North Texas Health Care System;
Roger Bedimo, M.D., M.S., The University of Texas Southwestern Medical Center, Dallas, Texas and the Dallas Veterans Affairs Medical Center;
Lance L. Goetz, M.D., The University of Texas Southwestern Medical Center, Dallas, Texas and the Dallas Veterans Affairs Medical Center